| Current Price | $68.06 | Mkt Cap | $16.1B |
|---|---|---|---|
| Open | $70.74 | P/E Ratio | 17.10 |
| Prev. Close | $72.26 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $67.83 - $71.74 | Volume | 1,347,949 |
| 52-Wk Range | $65.07 - $86.29 | Avg. Daily Vol. | 1,572,035 |
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
| Current Price | $68.06 | Mkt Cap | $16.1B |
|---|---|---|---|
| Open | $70.74 | P/E Ratio | 17.10 |
| Prev. Close | $72.26 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $67.83 - $71.74 | Volume | 1,347,949 |
| 52-Wk Range | $65.07 - $86.29 | Avg. Daily Vol. | 1,572,035 |
The best Bull and Bear pitches based on recency and number of recommendations.
The setback on its RA drug with LLY offers an attractive entry into this intriguing drug developer. With Jakafi sales growth (and profitability) and the potential for a best-in-class IDO-inhibitor (with data coming up), I think this company deserves… More
Jakafi revenue of 21M for Q1 was respectable but that number will like have to go much higher before Incyte will come close to neutralizing their hefty quarterly burn. Aside from preliminary data from the phase IIb trial of LY3009104 in rheumatoid… More
Read the most recent pitches from players about INCY.
Recs
SBCAI
(36.65)
Submitted: 12/19/2021 5:48:28 PM :
Start Price:
$72.72
NASDAQ:INCY Score:
+7.25
Incyte Corporation (INCY) is a Biopharmaceutical company who overall expertise is in the discovery, development and the commercialization of proprietary therapeutics throughout the United States and the world. (SBCAI Index- 17.7 Strong Buy)
Recs
smylar
(< 20)
Submitted: 10/24/2021 8:40:17 PM :
Start Price:
$65.83
NASDAQ:INCY Score:
+17.27
High market cap and has pulled back considerably
Recs
TMFBigFrog
(85.85)
Submitted: 10/4/2018 9:03:21 AM :
Start Price:
$69.76
NASDAQ:INCY Score:
-37.00
Relatively reasonable risk/reward profile in a crazy industry.
Find the members with the highest scoring picks in INCY.
mcmartinson (< 20) Score: +2,501.53
The Score Leader is the player with the highest score across all their picks in INCY.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| sara1985 | 96.71 | 4/6/2009 |
|
NS | $2.35 | +2,805.96% | +376.20% | +2,429.75 | 0 Comment | |
| dkelleher83 | 41.22 | 3/26/2009 |
|
NS | $2.44 | +2,698.77% | +380.85% | +2,317.92 | 0 Comment | |
| emmtom1 | < 20 | 5/27/2009 |
|
1Y | $2.94 | +2,223.18% | +333.91% | +1,889.27 | 0 Comment | |
| TaooaT | 93.13 | 5/11/2009 |
|
3Y | $3.03 | +2,153.80% | +332.80% | +1,821.00 | 0 Comment | |
| baylesbrothers | < 20 | 6/22/2009 |
|
5Y | $3.27 | +1,988.38% | +333.10% | +1,655.28 | 0 Comment | |
| ovrsxdunderpaid | < 20 | 6/12/2009 |
|
5Y | $3.35 | +1,938.51% | +320.42% | +1,618.09 | 0 Comment | |
| rffoss | 48.15 | 5/12/2009 |
|
3Y | $3.33 | +1,950.75% | +333.14% | +1,617.61 | 0 Comment | |
| want2retirenow | 75.36 | 6/1/2009 |
|
5Y | $3.35 | +1,938.51% | +323.71% | +1,614.80 | 0 Comment | |
| slimjim2005007 | < 20 | 6/10/2009 |
|
3M | $3.42 | +1,896.78% | +319.16% | +1,577.62 | 1 Comment | |
| FoolInNY | 25.84 | 6/4/2009 |
|
5Y | $3.54 | +1,829.10% | +320.22% | +1,508.87 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
